538 related articles for article (PubMed ID: 19445444)
21. Use of respiratory function tests to predict survival in amyotrophic lateral sclerosis.
Baumann F; Henderson RD; Morrison SC; Brown M; Hutchinson N; Douglas JA; Robinson PJ; McCombe PA
Amyotroph Lateral Scler; 2010; 11(1-2):194-202. PubMed ID: 19452343
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary functions in Parkinson's disease.
Sathyaprabha TN; Kapavarapu PK; Pall PK; Thennarasu K; Raju TR
Indian J Chest Dis Allied Sci; 2005; 47(4):251-7. PubMed ID: 16255396
[TBL] [Abstract][Full Text] [Related]
23. Incidence and prevalence of amyotrophic lateral sclerosis in Uruguay: a population-based study.
Vázquez MC; Ketzoián C; Legnani C; Rega I; Sánchez N; Perna A; Penela M; Aguirrezábal X; Druet-Cabanac M; Medici M
Neuroepidemiology; 2008; 30(2):105-11. PubMed ID: 18334826
[TBL] [Abstract][Full Text] [Related]
24. [Changes in the incidence and clinical features of ALS in the Koza, Kozagawa, and Kushimoto area of the Kii Peninsula--from the 1960s to the 2000s (follow-up study)].
Kihira T; Yoshida S; Murata K; Ishiguti H; Kondo T; Kohmoto J; Okamoto K; Kokubo Y; Kuzuhara S
Brain Nerve; 2010 Jan; 62(1):72-80. PubMed ID: 20112794
[TBL] [Abstract][Full Text] [Related]
25. [Laryngological presentation of patients with amyotrophic lateral sclerosis (ALS)].
Tomik J; Tomik B; Wiatr M; Składzień J
Przegl Lek; 2006; 63(11):1198-200. PubMed ID: 17348415
[TBL] [Abstract][Full Text] [Related]
26. Incidence of ALS in Lombardy, Italy.
Beghi E; Millul A; Micheli A; Vitelli E; Logroscino G;
Neurology; 2007 Jan; 68(2):141-5. PubMed ID: 17210896
[TBL] [Abstract][Full Text] [Related]
27. A clinical pilot study: high frequency chest wall oscillation airway clearance in patients with amyotrophic lateral sclerosis.
Chaisson KM; Walsh S; Simmons Z; Vender RL
Amyotroph Lateral Scler; 2006 Jun; 7(2):107-11. PubMed ID: 16753975
[TBL] [Abstract][Full Text] [Related]
28. Short-term outcome of olfactory ensheathing cells transplantation for treatment of amyotrophic lateral sclerosis.
Chen L; Huang H; Zhang J; Zhang F; Liu Y; Xi H; Wang H; Gu Z; Song Y; Li Y; Tan K
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Sep; 21(9):961-6. PubMed ID: 17933231
[TBL] [Abstract][Full Text] [Related]
29. Electrophysiological assessment of corticorespiratory pathway function in amyotrophic lateral sclerosis.
Shimizu T; Komori T; Kugio Y; Fujimaki Y; Oyanagi K; Hayashi H
Amyotroph Lateral Scler; 2010; 11(1-2):57-62. PubMed ID: 19707909
[TBL] [Abstract][Full Text] [Related]
30. Sensitivity and specificity of the 'Awaji' electrodiagnostic criteria for amyotrophic lateral sclerosis: retrospective comparison of the Awaji and revised El Escorial criteria for ALS.
Boekestein WA; Kleine BU; Hageman G; Schelhaas HJ; Zwarts MJ
Amyotroph Lateral Scler; 2010 Dec; 11(6):497-501. PubMed ID: 20536375
[TBL] [Abstract][Full Text] [Related]
31. Predicting respiratory insufficiency in amyotrophic lateral sclerosis: the role of phrenic nerve studies.
Pinto S; Turkman A; Pinto A; Swash M; de Carvalho M
Clin Neurophysiol; 2009 May; 120(5):941-6. PubMed ID: 19342290
[TBL] [Abstract][Full Text] [Related]
32. Sniff nasal pressure: a sensitive respiratory test to assess progression of amyotrophic lateral sclerosis.
Fitting JW; Paillex R; Hirt L; Aebischer P; Schluep M
Ann Neurol; 1999 Dec; 46(6):887-93. PubMed ID: 10589541
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary function in multiple sclerosis without any respiratory complaints.
Altintas A; Demir T; Ikitimur HD; Yildirim N
Clin Neurol Neurosurg; 2007 Apr; 109(3):242-6. PubMed ID: 17046152
[TBL] [Abstract][Full Text] [Related]
34. Factors correlated with NPPV use in ALS.
Jackson CE; Lovitt S; Gowda N; Anderson F; Miller RG
Amyotroph Lateral Scler; 2006 Jun; 7(2):80-5. PubMed ID: 16753971
[TBL] [Abstract][Full Text] [Related]
35. The ALSFRSr predicts survival time in an ALS clinic population.
Kaufmann P; Levy G; Thompson JL; Delbene ML; Battista V; Gordon PH; Rowland LP; Levin B; Mitsumoto H
Neurology; 2005 Jan; 64(1):38-43. PubMed ID: 15642901
[TBL] [Abstract][Full Text] [Related]
36. An observational study of cognitive impairment in amyotrophic lateral sclerosis.
Rippon GA; Scarmeas N; Gordon PH; Murphy PL; Albert SM; Mitsumoto H; Marder K; Rowland LP; Stern Y
Arch Neurol; 2006 Mar; 63(3):345-52. PubMed ID: 16533961
[TBL] [Abstract][Full Text] [Related]
37. Cognitive deficits in amyotrophic lateral sclerosis evaluated by event-related potentials.
Ogawa T; Tanaka H; Hirata K
Clin Neurophysiol; 2009 Apr; 120(4):659-64. PubMed ID: 19342291
[TBL] [Abstract][Full Text] [Related]
38. Demographic characteristics and prognosis in a Flemish amyotrophic lateral sclerosis population.
Thijs V; Peeters E; Theys P; Matthijs G; Robberecht W
Acta Neurol Belg; 2000 Jun; 100(2):84-90. PubMed ID: 10934559
[TBL] [Abstract][Full Text] [Related]
39. Phrenic nerve studies predict survival in amyotrophic lateral sclerosis.
Pinto S; Pinto A; de Carvalho M
Clin Neurophysiol; 2012 Dec; 123(12):2454-9. PubMed ID: 22762911
[TBL] [Abstract][Full Text] [Related]
40. Decreased cerebrospinal fluid cytochrome c levels in patients with amyotrophic lateral sclerosis.
Iłzecka J
Scand J Clin Lab Invest; 2007; 67(3):264-9. PubMed ID: 17454840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
